Overview

Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Trabeculectomy: A Study in Germany

Status:
Unknown status
Trial end date:
2011-11-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of this prospective randomized study is to investigate the efficacy and safety of trabeculectomy with ologen Collagen Matrix versus trabeculectomy using mitomycin C (MMC) in patients with medically uncontrolled open angle glaucoma.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Aeon Astron Europe B.V.
Treatments:
Mitomycin
Mitomycins
Criteria
Inclusion Criteria:

- Age 18 years or over

- Uncontrolled open-angle glaucoma

- Subject is willing to sign informed consent

- Subject is able and willing to complete post-operative follow-up requirements

Exclusion Criteria:

- Inflammatory eye diseases

- Angle-closure glaucoma

- Secondary glaucoma with anatomical malformations of the eye

- Subjects having single functional eye

- Previous conjunctival surgery

- Known allergic reactions to ingredients of ologen Collagen Matrix

- Excessive myopia (axial length (AL)> 27 mm or more than -10 diopters)

- Previous vitrectomy eye surgery

- Subjects do not consent to participate